glp-1 and yeast infections Semaglutide's Impact on Vaginal Health: What You Need to Know Do GLP-1 Medications Cause Yeast

AMPLITUDE-O with efpeglenatide, the latest GLP-1 RA CVOT to report (Gerstein et al., 2021), indeed indicated a benefit on HF, with post hoc analyses showing a significant 39% relative risk reduction on HF requiring hospitalisation (HR 0.61

The RR for achieving the primary outcome in the liraglutide group compared with the placebo was 4.7 (95% CI, 0.375.0

Seek immediate medical attention (A&E or call 999) if you develop: Severe, persistent abdominal pain radiating to the back (potential pancreatitis) Bloody or black, tarry stools Persistent vomiting with inability to keep down fluids Signs of severe dehydration or altered consciousness Symptoms of bowel obstruction (severe bloating, inability to pass gas or stool, severe cramping) For urgent but non-life-threatening concerns outside of GP hours, contact NHS 111 for advice

Biochim Biophys Acta 2001, 1546: 7986

Members can also decide they dont want to be on GLP-1s long term and use Virta as a safe and sustainable off-ramp to the drugs while maintaining a healthy weight

By inhibiting hepatic glucose production and promoting glucose uptake, GLP-1 receptor agonism counteracts dysregulated glucose metabolismdeterring insulin resistance in MASLD